RxDoctor Payments DataLook up a doctor →

Aaron Moorhouse, DO

Family Medicine · Meridian, IDNPI 1689602914

Payments from drug & device makers

$5,164in general payments, 2019–2025

Across 280 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$414
  • AbbVie$371
  • AstraZeneca$324
  • Novo Nordisk$293
  • Pfizer$265
  • Novartis$255
  • plus $3K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)23$414
AbbVie(2 entities)23$371
AstraZeneca19$324
Novo Nordisk16$293
Pfizer17$265
Novartis13$255
Abbott6$239
Johnson & Johnson11$176
Dexcom, Inc.5$146
GSK7$138
Otsuka America Pharmaceutical, Inc.7$138
Supernus Pharmaceuticals, Inc.9$134
Astellas Pharma US Inc8$132
Sunovion Pharmaceuticals Inc.9$128
Acadia Pharmaceuticals Inc4$127
Eisai Inc.6$105
Avanir Pharmaceuticals, Inc.5$90
Corcept Therapeutics4$83
Arbor Pharmaceuticals, Inc.5$74
E.r. Squibb & Sons, L.L.C.4$74
Boehringer Ingelheim4$70
Nestle Healthcare Nutrition Inc.3$70
Xeris Pharmaceuticals, Inc.3$68
Bayer3$68
Sanofi-aventis U.S. LLC4$67
Esperion Therapeutics, Inc.4$66
Merck4$64
Teva Pharmaceuticals USA, Inc.4$60
Vanda Pharmaceuticals Inc.3$56
Corium, LLC3$52
Medtronic1$48
Lilly USA, LLC3$47
Amarin Pharma, Inc.3$46
Idorsia Pharmaceuticals US Inc3$45
Takeda Pharmaceuticals U.S.A., Inc.3$41
Sumitomo Pharma America, Inc.2$40
Kyowa Kirin, Inc.2$39
Philips North America LLC1$38
Neurocrine Biosciences, Inc.2$38
Collegium Pharmaceutical, Inc.2$38
Stryker1$34
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$28
Acorda Therapeutics, Inc1$23
Exact Sciences1$22
Antares Pharma, Inc.1$22
Scilex Pharmaceuticals Inc.1$21
Boston Scientific1$21
Regeneron Healthcare Solutions, Inc.1$20
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$19
Axsome Therapeutics, Inc.1$19
Hologic Sales And Service, LLC1$19
Phathom Pharmaceuticals, Inc.1$19
Ultragenyx Pharmaceutical Inc.1$18
Therapeuticsmd, Inc.1$18
Otsuka Pharmaceutical Development & Commercialization, Inc.1$17
Genentech USA, Inc.1$17
Viatris Specialty LLC1$17
Mayne Pharma Commercial LLC2$16
Adlon Therapeutics L.p.1$15
Biohaven Pharmaceuticals, Inc.1$15

How this compares

$5,164 in reported general payments places this provider in the 90th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$74,715
Medicare patients
297
Services billed
861

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Meridian

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →